Samabriva is Set to Become a World Leader in Precision Biomanufacturing of Complex Molecules With the Announcement of a €4 Million Fundraising Round
The French biotechnology company Samabriva has successfully completed a Series-A round of financing to secure an investment of nearly €4 million.
- The French biotechnology company Samabriva has successfully completed a Series-A round of financing to secure an investment of nearly €4 million.
- Alongside their financial investment, they will bring a wealth of knowledge to help transform Samabriva into a leading CDMO.
- With lead investors like Noshaq and Investsud Tech now on board, this financing round will accelerate Samabriva’s growth.
- Marina Guillet, CEO of Samabriva - “We’re delighted that leading biotech investors have seen the incredible potential of Samabriva.